A
ADPT
Adaptive Biotechnologies
26.25
+0.70+2.74%Pre Market: 26.30 +0.05 +0.19%08:39 08/26 EDT
OPEN/PREV CLOSE25.81/25.55
TODAY RANGE25.23-26.49
VOL401
MARKET CAP4.19B
52 WEEK RANGE12.00-26.49
AVG VOL (3M)2.97M
% TURNOVER0.76%
TURNOVER0
P/E (TTM)-64.3540
% RANGE4.94%
EPS(TTM)-0.4079
P/E(FORWARD)-48.1926
P/B29.22
BVPS0.8985
DIVIDEND--
P/S14.57
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.10B
SHARES OUTSTANDING159.60M
NEXT EARNINGS11/03-11/09
FREE FLOAT156.06M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·3d ago
Adaptive Biotechnologies (ADPT) Stock Looks Fully Valued at Current Levels
Simply Wall St·08/18 15:18
Adaptive Biotechnologies (ADPT) Rebounds Sharply, Is The Stock Already Priced Fairly?
Simply Wall St·08/13 05:25
Adaptive Biotechnologies (ADPT) Stock Looks Fair On Cash Flow Yet Rich On Sales
Simply Wall St·08/11 09:36
Why Did Adaptive Biotechnologies (ADPT) Move After Its Latest Update?
Simply Wall St·08/09 15:32
Adaptive Biotechnologies (ADPT) Is Up 10.5% After Raising 2026 MRD Revenue Guidance Has The Bull Case Changed?
Simply Wall St·08/05 22:21
Adaptive Biotechnologies (ADPT) Stock Gains Little As MRD Growth Meets Wider Losses
Simply Wall St·08/04 20:32
Is Adaptive Biotechnologies (ADPT) Fairly Valued After Its MRD Split Plan?
TipRanks·08/04 13:29
Adaptive Biotechnologies (ADPT) Receives a Buy from Piper Sandler
Dow Jones·08/04 12:22
Adaptive Biotechnologies Is Maintained at Overweight by Piper Sandler
TipRanks·08/04 10:57
Adaptive Biotechnologies price target raised to $27.50 from $20 at Piper Sandler
Simply Wall St·08/02 12:19
Adaptive Biotechnologies (ADPT) Raised MRD Guidance, Is The Stock Fairly Valued?
Same Industry
Name/Symbol
Change%
Price